Treatment patterns and outcomes of immunotherapy in extensive‐stage small‐cell lung cancer based on real‐world practice

BACKGROUND: The application of immune checkpoint inhibitors (ICIs) represents a breakthrough in the current landscape for the treatment of extensive‐stage small‐cell lung cancer (ES‐SCLC), but the real‐world outcome is limited. This study aimed to investigate the treatment options and efficacy evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yaning, Ai, Xin, Xu, Haiyan, Yang, Guangjian, Yang, Lu, Hao, Xuezhi, Yang, Ke, Mi, Yuling, Wang, Guizhen, Zhang, Shuyang, Lei, Siyu, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715773/
https://www.ncbi.nlm.nih.gov/pubmed/36218023
http://dx.doi.org/10.1111/1759-7714.14684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715773/
https://www.ncbi.nlm.nih.gov/pubmed/36218023
http://dx.doi.org/10.1111/1759-7714.14684

Ejemplares similares